590417-95-1

Usage

Uses

Used in Pharmaceutical Industry:
6-BROMO-2-METHYL-2H-INDAZOLE is used as a building block for the development of new drugs, contributing to the creation of innovative pharmaceutical compounds.
Used in Research and Development Laboratories:
6-BROMO-2-METHYL-2H-INDAZOLE is used as a reagent for organic synthesis, aiding in the advancement of scientific research and the discovery of novel organic compounds.
Used in Organic Synthesis:
6-BROMO-2-METHYL-2H-INDAZOLE is used as a key intermediate in the synthesis of various organic compounds, facilitating the development of new chemical entities with potential applications in various fields.

InChI:InChI=1/C8H7BrN2/c1-11-5-6-2-3-7(9)4-8(6)10-11/h2-5H,1H3

Upstream product

• 79762-54-2 6-bromo-1H-indazole 
• 74-88-4 methyl iodide 

Downstream Products

• 50593-30-1 2-methyl-2H-indazol-6-amine 

Relevant academic research and scientific papers

COMPOUNDS AND USES THEREOF

The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES

Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).

N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and compounds I for use to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).